Jakrif-5 Tablet

Jakrif-5 Tablet সম্পর্কে

বাংলাদেশে Jakrif-5 Tablet ট্যাবলেট হিসেবে পাওয়া যায়; এতে Tofacitinib আছে (৫ mg)। Tofacitinib-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। এই ব্র্যান্ডের প্রস্তুতকারক Renata PLC। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।

Tofacitinib-এর ১৩টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Tofacit 5 mg Tablet-এর, প্রতি ইউনিট ৳ ৩০.০০।

Jakrif-5 Tablet কী?

Jakrif-5 is a tablet made by Renata PLC. It contains tofacitinib 5 mg, an immunosuppressant. It is used in adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or cannot tolerate methotrexate. It may be taken alone or with methotrexate or other nonbiologic disease-modifying antirheumatic drugs. Tofacitinib works by blocking certain immune signals involved in joint inflammation. Because it affects the immune system, it needs medical supervision. Ask your doctor or pharmacist about anything you are unsure of.

Jakrif-5-এর ব্যবহার

Jakrif-5 is used for adults with moderately to severely active rheumatoid arthritis after methotrexate has not worked well enough or has caused intolerance. It can be used on its own or together with methotrexate or other nonbiologic disease-modifying antirheumatic drugs. It is not a painkiller for everyday aches. Tell your doctor about all your health conditions and other medicines.

Jakrif-5 কীভাবে ব্যবহার করবেন

Take Jakrif-5 exactly as your doctor tells you. The dose and course are decided by your doctor based on your condition and other medicines you take. Swallow the tablet as instructed. Do not change the dose or stop treatment on your own. If you miss a dose, ask your doctor or pharmacist what to do. Keep all appointments for check-ups and tests your doctor advises.

Jakrif-5-এর পার্শ্বপ্রতিক্রিয়া

In clinical trials during the first three months, the most commonly reported side effects were upper respiratory tract infections, headache, diarrhoea and nasopharyngitis. Some people may have other effects. Because tofacitinib affects the immune system, serious infections can occur. Tell your doctor promptly if you notice signs of infection, such as fever, or any unusual symptom. Ask your doctor or pharmacist about what to watch for.

সতর্কতা ও নিরাপত্তা

Jakrif-5 should not be used during an active serious infection, including localised infections. It is used with caution in people who may be at increased risk of gastrointestinal perforation. Your doctor may arrange laboratory monitoring because of possible changes in blood cells, liver enzymes and lipids. Live vaccines should be avoided with this medicine. Do not start it if certain blood counts are low; your doctor will check. It is pregnancy category C: use in pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether tofacitinib passes into human milk, so breastfeeding decisions need medical advice. Tell your doctor about pregnancy, breastfeeding, infections or other medicines before starting.

সাধারণ প্রশ্ন

What does the generic name tofacitinib mean?

Tofacitinib is the generic name of the active ingredient. It belongs to a group of medicines called janus kinase (JAK) inhibitors. These medicines work by blocking certain immune signals in the body. Jakrif-5 is the brand name of this tofacitinib tablet.

What is Jakrif-5 used for and what kind of medicine is it?

Jakrif-5 is an immunosuppressant tablet. It is used for adults with moderately to severely active rheumatoid arthritis who have had an inadequate response to methotrexate or cannot tolerate it. It may be used alone or with methotrexate or other nonbiologic disease-modifying antirheumatic drugs.

How should Jakrif-5 be taken?

Your doctor decides the dose and how long you take Jakrif-5. Follow their instructions exactly and do not change the dose yourself. If you miss a dose or have questions about taking it, ask your doctor or pharmacist. Keep any appointments for monitoring that your doctor advises.

What should I tell my doctor before starting Jakrif-5?

Tell your doctor about any current or past infections, pregnancy or breastfeeding, liver or kidney problems, and all other medicines you take. Your doctor will assess whether Jakrif-5 is suitable for you and may arrange blood tests. Do not start it during an active serious infection.

Tablet
জেনেরিক নাম
Tofacitinib
শক্তি
5 mg
ডোজ ফর্ম
Tablet
প্রস্তুতকারক
Renata PLC.

নির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Rheumatoid Arthritis: Tofacitinib is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. It may be used as monotherapy or in combination with methotrexate or other nonbiologic ... Read moreRheumatoid Arthritis: Tofacitinib is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. It may be used as monotherapy or in combination with methotrexate or other nonbiologic disease-modifying antirheumatic drugs (DMARDs).

Psoriatic Arthritis: Tofacitinib is indicated for the treatment of adult patients with active psoriatic arthritis who have had an inadequate response or intolerance to methotrexate or other disease-modifying antirheumatic drugs (DMARDs).

Ulcerative Colitis: Tofacitinib is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (UC).

ফার্মাকোলজি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Rheumatoid arthritis is an autoimmune disease characterized by a dysregulation of pro-inflammatory cytokines including IL7, IL15, IL21, IL6, IFN-alpha, and IFN-beta. (3) Cytokines signalling results in tissue inflammation and joint damage by stimulating the recruitment and activation of immune cells via the janus kinase signalling pathway.

Tofacitinib is a partial and reversible janus kinase (JAK) inihibitor that will prevent the body from responding to cytokine signals. By inhibiting JAKs, tofacitinib prevents the phosphorylation and activation of STATs. The JAK-STAT signalling pathway is involved in the transcription of cells involved in hematopoiesis, and immune cell function. Tofacitinib works therapeutically by inhibiting the JAK-STAT pathway to decrease the inflammatory response. However, there is evidence to suggest that it may also achieve efficacy via other pathways as well.

মাত্রা ও সেবনবিধি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Rheumatoid Arthritis: Tofacitinib 5 mg twice daily or Tofacitinib 11 mg once daily. Recommended dosage in patients with moderate and severe renal impairment or moderate hepatic impairment is Tofacitinib 5 mg once daily.

Psoriatic Arthritis (in combination with nonbiologic DMARDs): Tofacitinib 5 mg twice daily or Tofacitinib 11 mg once daily.  Recommended dosage in patients with moderate and severe renal impairment or moderate hepatic impairment is Tofacitinib 5 mg once daily.

Ulcerative Colitis: Tofacitinib 10 mg twice daily for at least 8 weeks; then 5 or 10 mg twice daily. Discontinue after 16 weeks of 10 mg twice daily, if adequate therapeutic benefit is not achieved. Use the lowest effective dose to maintain response.

ঔষধের মিথষ্ক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

  • Potent inhibitors of Cytochrome P450 3A4 (CYP3A4) (e.g., Ketoconazole)
  • Recommended dose is Tofacitinib 5 mg once daily: One or more concomitant medications that result in both moderate inhibition of CYP3A4 and potent inhibition of CYP2C19 (e.g., fluconazole)
  • Recommended dose is Tofacitinib 5 mg once daily Potent CYP inducers (e.g.Rifampin): May result in loss of or reduced clinical response.

পার্শ্ব প্রতিক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

The most commonly reported adverse reactions during the first 3 months in controlled clinical trials (occurring in greater than or equal to 2% of patients treated with Tofacitinib monotherapy or in combination with DMARDs) were upper respiratory tract infections, headache, diarrhea and nasopharyngitis.

গর্ভাবস্থায় ও স্তন্যদানকালে

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Pregnancy Category C. There are no adequate and well controlled studies in pregnant women. Tofacitinib should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

It is not known whether Tofacitinib is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Tofacitinib, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug for the mother

সতর্কতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

  • Serious Infections: Avoid use of Tofacitinib during an active serious infection, including localized infections. 
  • Gastrointestinal Perforations: Use with caution in patients that may be at increased risk.
  • Laboratory Monitoring: Recommended due to potential changes in lymphocytes, neutrophils, hemoglobin, liver enzymes and lipids.
  • Immunizations: Live vaccines: Avoid use with Tofacitinib.
  • Do not initiate Tofacitinib if absolute lymphocyte count <500 cells/mm3, an absolute neutrophil count (ANC) <1000 cells/mm3 or hemoglobin <9 gm/dL.

সংরক্ষণ

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Store below 30°C. Protect from light & moisture. Keep all medicines out of the reach of children.

বিকল্প ব্র্যান্ড: Tofacitinib

একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।

Tofacit Tablet

5 mg

Tofacitinib

Delta Pharma Limited

৳ ২৯.৪ ৳ ৩০.০০ ২% ছাড় প্রতি ইউনিট

Tofanib Tablet

5 mg

Tofacitinib

Globe Pharmaceuticals Ltd.

৳ ৪৭.০৪ ৳ ৪৮.০০ ২% ছাড় প্রতি ইউনিট

Tofacit XR Xr Tablet

11 mg

Tofacitinib

Delta Pharma Limited

৳ ৫৮.৮ ৳ ৬০.০০ ২% ছাড় প্রতি ইউনিট

Tofanib XR Xr Tablet

11 mg

Tofacitinib

Globe Pharmaceuticals Ltd.

৳ ৭৮.৪ ৳ ৮০.০০ ২% ছাড় প্রতি ইউনিট

Tofu Tablet

5 mg

Tofacitinib

Chemist Laboratories Ltd.

দাম দেওয়া নেই

Xelnib 5 Tablet

5 mg

Tofacitinib

Opsonin Pharma Limited

দাম দেওয়া নেই

ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।